A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression

Archives of General Psychiatry

Volumn 54, Issue 11, 1997, Pages 1031-1037

  Emslie, Graham J ^a   John Rush, A ^a   Weinberg, Warren A ^b   Kowatch, Robert A ^a   Hughes, Carroll W ^c   Carmody, Tom ^a   Rintelmann, Jeanne ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Terrell State Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PLACEBO;

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT OUTCOME;

EID: 1842413623     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1997.01830230069010     Document Type: Article

References (42)

1. Fleming JE, Offord DR. Epidemiology of childhood depressive disorders: a critical review. J Am Acad Child Adolesc Psychiatry. 1990;29:571-580.
2. Weinberg W, Rehmet A. Childhood affective disorder and school problems. In: Cantwell DP, Carlson GA, eds. Affective Disorders in Childhood and Adolescence: An Update. Jamaica, NY: Spectrum Publishing Inc; 1983:109-128.
3. Weinberg W, Emslie G. Adolescents and school problems: depression, suicide, and learning disorders. Adv Adoiesc Ment Health. 1988;3:181-205.
4. Brent DA. Correlates of the medical lethality of suicide attempts in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1987;26:87-91.
5. Pfeffer CR, Klerman GL, Hurt SW, Lesser M, Peskin JR, Siefker CA. Suicidal children grow up: demographic and clinical risk factors for adolescent suicide attempts. J Am Acad Child Adoiesc Psychiatry. 1991;30:609-616.
6. Rao U, Weissman MM, Martin JA, Hammond RW. Childhood depression and risk of suicide: a preliminary report of a longitudinal study. J Am Acad Child Adoiesc Psychiatry. 1993;32:21-27.
7. Kovacs M, Gatsonis C. Secular trends in age at onset of major depressive disorder in a clinical sample of children. J Psychiatr Res. 1994;28:319-329.
8. Hazell P, O'Connell D, Heathcote D, Robertson J, Henry D. Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis. BMJ. 1995; 310:897-901.
9. Boulos C, Kutcher S, Gardner D, Young E. An open naturalistic trial of fluoxetine in adolescents and young adults with treatment-resistant major depression. J Child Adoiesc Psychopharmacol. 1992;2:103-111.
10. Ghaztuddin N, Naylor MW, King CA. Fluoxetine in tricyclic refractory depression in adolescents. Depression. 1995;2:287-291.
11. Jain U, Birmaher B, Garcia M, Al-Shabbout M, Ryan N. Flouxetine in children and adolescents with mood disorders: a chart review of efficacy and adverse effects. J Child Adolesc Psychopharmacol. 1992;2:259-265.
12. Tierney E, Paramjit JT, Leinas JF, Rosenberg LA, Riddle MA. Sertraline for major depression in children and adolescents: preliminary clinical experience. J Child Adolesc Psychopharmacol. 1995;5:13-27.
13. Simeon J, Dinicola V, Ferguson HB, Copping W, Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up. Prog Neuropsychopharmacol Biol Psychiatry. 1990;14:791-795.
14. Baldessarini RJ. Current status of antidepressants: clinical pharmacology and therapy. J Clin Psychiatry. 1989;50:117-126.
15. Trivedi MH, Rush AJ. Efficacy of antidepressant medications, part 1: a metaanalysis. Neuropsychopharmacology. In press.
16. Thase ME, Trivedi MH, Rush AJ. MAOIs in the contemporary treatment of depression. Neuropsychopharmacology. 1995;12:185-219.
17. Clinical Practice Guideline Number 5: Depression in Primary Care, 2: Treatment of Ma/or Depression. Rockville, Md: US Dept of Health and Human Services, Agency for Health Care Policy and Research; 1993. Health Care Policy and Research publication 93-0551.
18. Kutcher S, Boulos C, Ward B, Marton P, Simeon J, Ferguson HB, Szalai J, Katic M, Roberts N, Dubois C, Reed K. Response to desipramine treatment in adolescent depression: a fixed-dose, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 1994;33:686-694.
19. Ryan ND. Pharmacotherapy of adolescent major depression: beyond TCAs. Psychopharmacol Bull. 1990;26:75-79.
20. Black IB, Hendry IA, Iversen LL. Trans-synaptic regulation of growth and development of adrenergic neurons in a mouse sympathetic ganglion. Brain Res. 1971; 24:229-240.
21. Goldman-Rakic CP, Brown RM. Postnatal development of monoamine content and synthesis in the cerebral cortex of rhesus monkeys. Dev Brain Res. 1982;4:339-349.
22. Conners CK. Methodology of antidepressant drug trials for treating depression in adolescents. J Child Adolesc Psychopharmacol. 1992;2:11-22.
23. Jensen PS, Ryan ND, Prien R. Psychopharmacology of child and adolescent major depression: present status and future directions. J Child Adolesc Psychopharmacol. 1992;2:31-45.
24. Strober M. The pharmacotherapy of depressive illness in adolescents, III: diagnostic and conceptual issues in studies of tricyclic antidepressants. J Child Adolesc Psychopharmacol. 1992;2:23-29.
25. Herjanic B, Reich W. Development of a structured psychiatric interview for children: agreement between child and parent on individual symptoms. J Abnorm Child Psychol. 1982;10:307-324.
26. Welner Z, Reich W, Herjanic B, Jung KG, Amado H. Reliability, validity, and parent-child agreement studies of the Diagnostic Interview for Children and Adolescents (DICA). J Am Acad Child Adolesc Psychiatry. 1987;26:649-653.
27. Chambers WJ, Puig-Antich J, Hirsch M, Paez P, Ambrosini PJ, Tabrizi MA, Davies M. The assessment of affective disorders in children and adolescents by semistructured interview: test-retest reliability of the K-SADS-P. Arch Gen Psychiatry. 1985;42:696-702.
28. Poznanski EO, Freman LN, Mokros HB. Children's Depression Rating Scale - Revised (September 1984). Psychopharmacol Bull. 1985;21:979-989.
29. Kovacs M. The Children's Depression Inventory (GDI). Psychopharmacol Bull. 1985;21:995-998.
30. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
31. Weinberg WA, Emslie GJ. Weinberg Screening Affective Scale (WSAS and WSASSF). J Child Neurol. 1988;3:294-296.
32. Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwahlia S. A Children's Global Assessment Scale (CGAS) (for children 4 to 16 years of age). Psychopharmacol Bull. 1985;21:747-748.
33. Overall JE, Pfefferbaum B. The Brief Psychiatry Rating Scale for Children. Psychopharmacol Bull. 1982;18:10-16.
34. Fleiss JL. The Design and Analysis of Clinical Experiments. New York, NY: John Wiley & Sons Inc; 1986.
35. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: John Wiley & Sons Inc; 1981.
36. Kraemer HC, Thieman S. A strategy to use soft data effectively in randomized controlled clinical trials. J Consult Clin Psychol. 1989;57:148-154.
37. Mori M, Woodworth GG, Woolson RF. Application of empirical Bayes inference to estimation of rate of change in the presence of informative right censoring. Stat Med. 1992;11:621-631.
38. Kaplin EL, Meter P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
39. Puig-Antich J, Perel JM, Lupatkin W, Chambers WJ, Tabrizi MA, King J, Goetz R, Davies M, Stiller RL. Imipramine in prepubertal major depressive disorders. Arch Gen Psychiatry. 1987;44:81-89.
40. Puig-Antich J, Perel JM, Lupatiktn W, Chambers WJ, Shea C, Tabrizi MA, Stiller RL. Plasma levels of imipramine (IMI) and desmethylimipramine (DMI) and clinical response in prepubertal major depressive disorder: a preliminary report. J Am Acad Child Psychiatry. 1979;18:616-627.
41. Geller B, Cooper TB, McCombs HG, Graham DL, Wells J. Double-blind, placebocontrolled study of nortriptyline in depressed children using a 'fixed plasma level' design. Psychopharmacol Bull. 1989;25:101-108.
42. Geller B, Cooper TB, Graham DL, Marsteller FA, Bryant DM. Double-blind, placebocontrolled study of nortriptyline in depressed adolescents using a 'fixed plasma level' design. Psychopharmacol Bull. 1990;26:85-90.